Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Affilogic Logo
Affilogic Growth Score
85
CB Rank
431107
Heat Score
66
Scaffolds for Diagnostics & Therapeutic
Founded
obfuscation
Private Nantes, Pays de la Loire, France11-50 www.affilogic.com
Biotechnology
Health Diagnostics
Overview

Affilogic
Growth Score
85
Heat Score
66

Growth Score85
-2 pts
in past quarter
Heat Score 66
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Affilogic

CB Rank
431107
Scaffolds for Diagnostics & Therapeutic
Founded
obfuscation
Private Nantes, Pays de la Loire, France11-50 www.affilogic.com
Biotechnology
Health Diagnostics

Key People

Details

Operating Status Active
Company Type For Profit
About the Company
Affilogic develops custom affinity proteins as an alternative for Antibodies in the fields of Bioprocessing, Diagnostics and Therapeutic applications.
Contact Email olivier@affilogic.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Nanofitins®
Small, stable protein scaffolds used as antibody mimetics for therapeutic and diagnostic applications, capable of binding specific biological targets.
APL-1030
A Nanofitin-based inhibitor targeting complement proteins C3 and C3b to inhibit complement pathway activation in immune-related diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 9

Employee Profiles

News

News and Press

News•Jun 22, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 22, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

240
23.08%
 in past month

IT Spend

$302.4KThis year, Affilogic is projected to spend $302.4K on IT, according to Aberdeen.

Actively Used Products

8Affilogic uses 8 technology products and services including HTML5, Vimeo, and  Wordpress, according to G2 Stack.

Active Website Tech Count

5Affilogic is actively using 5 technologies for its website, according to BuiltWith. These include Common Crawl, Font Awesome, and  CommonCrawl Top 5m.

Total IP

22The intellectual property of Affilogic includes 14 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Affilogic has registered 8 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Affilogic's headquarters? Affilogic is located in Nantes, Pays de la Loire, France.Who are Affilogic's competitors? Alternatives and possible competitors to Affilogic may include Merck, BioNTech, and  GSK.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|